News & Events
Your location:
Home
/
/
/
Beijing pharmaceutical enterprises financing sharing meeting held in haibu pharmaceutical grand

Beijing pharmaceutical enterprises financing sharing meeting held in haibu pharmaceutical grand

(Summary description)On May 10, 2019, Beijing pharmaceutical enterprises financing sharing meeting was grandly held in  HOPE pharmaceutical. It gathered 33 pharmaceutical enterprises in Beijing, including baiaosaitu, Remebot, China resources medicine and yangzijiang, and 27 investment institutions, including tongchuang weiye, puhua, junlian and mifang. We got together to discuss the financing of Beijing pharmaceutical enterprises.

Beijing pharmaceutical enterprises financing sharing meeting held in haibu pharmaceutical grand

(Summary description)On May 10, 2019, Beijing pharmaceutical enterprises financing sharing meeting was grandly held in  HOPE pharmaceutical. It gathered 33 pharmaceutical enterprises in Beijing, including baiaosaitu, Remebot, China resources medicine and yangzijiang, and 27 investment institutions, including tongchuang weiye, puhua, junlian and mifang. We got together to discuss the financing of Beijing pharmaceutical enterprises.

Information

On May 10, 2019, Beijing pharmaceutical enterprises financing sharing meeting was grandly held in  HOPE pharmaceutical. It gathered 33 pharmaceutical enterprises in Beijing, including baiaosaitu, Remebot, China resources medicine and yangzijiang, and 27 investment institutions, including tongchuang weiye, puhua, junlian and mifang. We got together to discuss the financing of Beijing pharmaceutical enterprises.

The conference is jointly organized by tongchuang weiye, PWC capital, HOPE medicine, probe capital and kai yuen capital. There are "before the next round of financial norms and planning" and "enterprise different development stage of legal problems", "sea step medicine, lab view", "pharmaceutical enterprise management to discuss", "make financing more efficient", "CEO need to understand the key points of financing," a line of medical investment institutions analysis "seven plates, share the guests in turn from the enterprise financial, legal, operational management, investment and financing Angle, taught the actual combat experience in the process of corporate finance. The meeting was chaired by li Yang, director of PWC capital investment.

Chen jianqiang, post_investment director of PWC capital, Shared the theme of "financial norms and planning before the next round of financing". There are many details to be considered when making financial regulations, such as financing subjects, related transactions, personnel costs (salary, social security), potential liabilities, etc. Financial planning should consider business closed loop, shareholding platform, share payment, listing channels, etc. Chen identified 10 major issues that companies need to pay attention to, including equity flaws, other business investments not related to their main business, and bill compliance issues. For example, when it comes to capital occupation, a market reference value (such as the loan interest rate of the bank in the same period) should be used to calculate the reasonable cost of capital. The best solution is for shareholders to lend money to the bank and then lend to the company.

 

Discussion on enterprise financial management, presided by Chen jianqiang. Answered questions about the financing of the new third board. He believes that the big problem of the new third board is that the user threshold is too high, and then the financing is difficult because of the mechanism of information transparency.

 

The theme Shared by yuan yichao, founder of wanshang tianqin law firm, is "legal issues in different development stages of enterprises". I. capital contribution and transfer by shareholders: the author shares the following aspects respectively: the penetration of limited liability, the problems existing in the investment of intellectual property rights and their solutions, the tax problem of the transfer of capital reserve to equity capital, the tax principles and declaration situation of equity transfer, and the similarities and differences between joint stock companies and limited companies. 2. Equity structure and equity incentive: it emphasizes the importance of rational construction of equity structure and clear thinking of equity incentive for enterprise development; Iii. Basic and planning requirements of the capital market: the development dilemma and solutions of the enterprise are elaborated in combination with different development stages and compliance requirements of the enterprise; 4. Ways to improve the performance of enterprises __ merger and acquisition and incubation mode: provide effective ways to improve the performance of enterprises based on my years of experience in corporate legal services; V. protection of intellectual property rights: considering that pharmaceutical enterprises are an intensive industry of intellectual property rights, we provide comprehensive Suggestions for the protection of intellectual property rights from the perspectives of external risks and internal management of intellectual property rights and in combination with detailed cases.

 

Discussion on corporate legal affairs was conducted by yuan yichao. Some enterprises asked: the actual controller of the invested enterprise is a foreigner, who holds the equity of the enterprise on behalf of others. The investor requires an effective binding of the responsibility of the enterprise and the actual controller, and how to operate it. Lawyer yuan believes that the core of this matter lies in how the investor limits the obligations of the actual controller. Second, the actual controller can be listed in the agreement as the core personnel of the enterprise and the joint and several obligations of the core personnel can be added.

 

Zhang fang, vice_president of probe capital, Shared the theme of "making financing more efficient". She Shared her years of experience in investment and financing, which led to a more efficient methodology for financing. Zhang Fang around corporate finance including BP involved writing, formulation screening, communication skills, value investors, financing risk control and efficiency improvement and so on each link system on and analysis of the enterprise in the process of financing needs to focus on matters and shall master the skills of the participating entrepreneurs to key issues in corporate finance has a clear understanding and the understanding; In addition, in view of the important role in the process of PR in corporate finance, Zhang Fang through a well_known company in the field of medical imaging in the successful financing experience in 2018 as an example, introduced in detail, the media interview, professional awards selection, WeChat platform exposure PR means such as the flexible application of success to help enterprises under the condition of low capital environment for two rounds of financing, vivid case analysis can help entrepreneurs recognize the important role of PR and publicity for attending enterprises future point the right direction.

 

The theme Shared by jin xiao, founder of qiyuan capital, is "financing points for ceos to understand". She mentioned, the choice of the financing point to consider account surplus capital, financing, financing amount, capital market present situation, the enterprise the milestone and industry/competitive factors, such as the situation at the same time starts to grasp the market window, avoid the front is too long, and in view of the different types of companies in 2019 financing strategy made in_depth explanation; For example, when a project in the hot air should receive more money, it is necessary to relax the mentality to release equity, strike while the iron is hot, and raise funds for the next two years, because no one can tell how long this hot air can last. At the same time, based on her years of financing experience, the key items that are prone to errors in the communication between enterprises and institutions in different stages are given, as well as the materials that can be provided to investors in various stages after the initial road show, Pre, DD and TS.

 

The topic Shared by xi yanbin, vice President of tongchuang weiye is "investment analysis of front_line institutions in medical investment". From the two dimensions of investment institutions in various provinces, regions and subdivided tracks, the investment situation in the primary medical market in 2018 is comprehensively analyzed, and the representative institutions are emphatically interpreted. Xi always explaining the objective analysis, obtained the participants frequently.

Enterprise operation and management roundtable BBS, presided over by liu changru, chairman of haibu medicine, participated in the discussion by wang wenfeng, CEO of China resources medicine (Beijing pharmaceutical research and development center), ding hongxia, CEO of yaodu, and wang chengzhen, deputy general manager of aotaikang. When we share our experience in business management, we emphasize that we should work hard on process management to make the organization run in an orderly way. At the same time, we should also pay attention to and strengthen the construction of enterprise information, improve the efficiency of enterprise management. According to the chairman of liu changru, she has summed up two sentences in her entrepreneurship for so many years. Second, we should try our best to reduce the organization's dependence on these personnel through management methods and means.

During the intermission of the meeting, under the leadership of chairman liu changru, the participants visited the laboratory of more than 4000 square meters of haibu medicine. All of us affirmed the exceptionally rigorous and meticulous field management of haibo laboratory and the forward_looking implementation of r&d informatization construction, and actively communicated with the staff of haibo on the spot. Currently, the company has a r&d team of nearly 200 people, which provides pharmaceutical and clinical CRO services, r&d, associated registration and customized production of high_end API and pharmaceutical intermediates for domestic and foreign pharmaceutical companies, said chairman liu changru. In the future, the research and development, production and sales of chemical pharmaceutical products will be increased. Chairman liu changru and xi yanbin, vice President of tongchuang weiye investment co., LTD., together, carefully explained how haibu medicine carefully cultivated the details of pharmaceutical research and development management, strengthened the information construction of research and development, and realized the leapfrog development of the company. Chairman liu changru finally concluded, "every scientific research worker of hibu must cherish the fear of life, uphold the scientific rigor, true_seeking and pragmatic spirit, keep improving and make technology and products perfect in every link of research and development."

 

This conference was full of people. Entrepreneurs and investors gathered together and had a very happy talk. No matter in the tea room or sofa area, there were always two or three people sitting around and exchanging ideas. "This session deepened my understanding of how to control the financing process and helped me focus more on the financial, legal and PR parts. In particular, the speakers gave a lot of examples, which helped me a lot in my thinking. Jian yi bao CEO zhang shengming said after the meeting. After the meeting, yan jingjing, a partner of probe capital, said, "we found that we have gained different things from this exchange, and we will hold more similar activities in the future. We can not only learn from each other, but also have resource collisions when we get together, which may produce some sparks. This is a very exciting thing."

Keyword:

Scan the QR code to read on your phone

  

Beijing Hope Pharmaceutical Co., Ltd.   京ICP备17065299号

这是描述信息